<p>Atossa Therapeutics Inc. has announced that it will hold a Special Meeting of Stockholders virtually on January 20, 2026. During the meeting, stockholders will be asked to approve a reverse stock split intended to increase the per share trading price of the company’s common stock and help maintain its listing on the Nasdaq Stock Market. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atossa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-317731), on December 12, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

ATOS

<p>Atossa Therapeutics Inc. will hold a virtual Special Meeting of Stockholders on January 20, 2026, to approve a reverse stock split aimed at increasing the trading price of its common stock and maintaining its Nasdaq listing.</p>

Atossa Therapeutics Inc. Announces Date for Upcoming Special Meeting of Stockholders